Patents by Inventor Michael D. Hack

Michael D. Hack has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Benzoimidazole compounds
    Publication number: 20090264647
    Abstract: Benzoimidazole compounds, compositions, and methods of using them in leukocyte recruitment inhibition, in modulating H4 receptor, and in treating conditions such as inflammation, H4 receptor-mediated conditions, and related conditions.
    Type: Application
    Filed: August 26, 2008
    Publication date: October 22, 2009
    Inventors: Kristen L. Arienti, James G. Breitenbucher, Daniel J. Buzard, James P. Edwards, Michael D. Hack, Alice Lee-Dutra
  • Benzoimidazole compounds
    Publication number: 20090264646
    Abstract: Benzoimidazole compounds, compositions, and methods of using them in leukocyte recruitment inhibition, in modulating H4 receptor, and in treating conditions such as inflammation, H4 receptor-mediated conditions, and related conditions.
    Type: Application
    Filed: August 26, 2008
    Publication date: October 22, 2009
    Inventors: James P. Edwards, Michael D. Hack, David E. Kindrachuk, Jennifer D. Venable
  • Benzoimidazole Compounds
    Publication number: 20090247508
    Abstract: Benzoimidazole compounds, compositions, and methods of using them in leukocyte recruitment inhibition, in modulating H4 receptor, and in treating conditions such as inflammation, H4 receptor-mediated conditions, and related conditions.
    Type: Application
    Filed: October 23, 2008
    Publication date: October 1, 2009
    Inventors: James P. Edwards, Michael D. Hack, David E. Kindrachuk, Jennifer D. Venable
  • Quinoxaline compounds
    Patent number: 7563895
    Abstract: Certain amidophenyl-sulfonylamino-quinoxaline compounds are CCK2 modulators useful in the treatment of CCK2 mediated diseases.
    Type: Grant
    Filed: December 4, 2007
    Date of Patent: July 21, 2009
    Assignee: Janssen Pharmaceutica, N.V.
    Inventors: Brett D. Allison, Michael D. Hack, Victor K. Phuong, Michael H. Rabinowitz, Mark D. Rosen
  • CCK-1 receptor modulators
    Patent number: 7465808
    Abstract: There are provided by the present invention certain pyrazole based CCK-1 receptor modulators.
    Type: Grant
    Filed: September 19, 2005
    Date of Patent: December 16, 2008
    Assignee: Janssen Pharmaceutica, N.V.
    Inventors: Terrance D. Barrett, J. Guy Breitenbucher, Laurent Gomez, Michael D. Hack, Liming Huang, Kelly J. McClure, Magda F. Morton, Clark A. Sehon, Nigel P. Shankley
  • CCK-1 receptor modulators
    Patent number: 7456208
    Abstract: Certain imidazole compounds are CCK1 modulators useful in the treatment of CCK1 mediated diseases.
    Type: Grant
    Filed: July 3, 2007
    Date of Patent: November 25, 2008
    Assignee: Janssen Pharmaceutica N.V.
    Inventors: J. Guy Breitenbucher, Michael D. Hack, Clark A. Sehon
  • Benzoimidazole compounds
    Patent number: 7432378
    Abstract: Benzoimidazole compounds, compositions, and methods of using them in leukocyte recruitment inhibition, in modulating H4 receptor, and in treating conditions such as inflammation, H4 receptor-mediated conditions, and related conditions.
    Type: Grant
    Filed: September 29, 2004
    Date of Patent: October 7, 2008
    Assignee: Janssen Pharmaceutica, N.V.
    Inventors: James P. Edwards, Michael D. Hack, David E. Kindrachuk, Jennifer D. Venable
  • Quinoxaline compounds
    Patent number: 7304051
    Abstract: Amidophenyl-sulfonylamino-quinoxaline compounds of formula (I) are CCK2 modulators useful in the treatment of CCK2 mediated diseases.
    Type: Grant
    Filed: August 4, 2004
    Date of Patent: December 4, 2007
    Assignee: Janssen Pharmaceutica N.V.
    Inventors: Brett D. Allison, Michael D. Hack, Victor K. Phuong, Michael H. Rabinowitz, Mark D. Rosen
  • CCK-1 receptor modulators
    Patent number: 7250434
    Abstract: Certain imidazole compounds are CCK1 modulators useful in the treatment of CCK1 mediated diseases.
    Type: Grant
    Filed: December 21, 2004
    Date of Patent: July 31, 2007
    Assignee: Janssen Pharmaceutica N.V.
    Inventors: J. Guy Breitenbucher, Michael D. Hack, Clark A. Sehon
  • CCK-1 receptor modulators
    Patent number: 7037931
    Abstract: There are provided by the present invention certain pyrazole based CCK-1 receptor modulators.
    Type: Grant
    Filed: July 2, 2003
    Date of Patent: May 2, 2006
    Assignee: Janssen Pharmaceutica N.V.
    Inventors: Terrance D. Barrett, J. Guy Breitenbucher, Laurent Gomez, Michael D. Hack, Liming Huang, Kelly J. McClure, Magda F. Morton, Clark A. Sehon, Nigel P. Shankley
  • CCK-1 receptor modulators
    Publication number: 20040067983
    Abstract: There are provided by the present invention certain pyrazole based CCK-1 receptor modulators.
    Type: Application
    Filed: July 2, 2003
    Publication date: April 8, 2004
    Inventors: Terrance D. Barrett, J. Guy Breitenbucher, Laurent Gomez, Michael D. Hack, Liming Huang, Kelly J. McClure, Magda F. Morton, Clark A. Sehon, Nigel P. Shankley